Amundi’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $130M | Sell |
394,179
-60,816
| -13% | -$20.1M | 0.04% | 363 |
|
|
2025
Q1 | $119M | Sell |
454,995
-41,306
| -8% | -$10.8M | 0.04% | 364 |
|
|
2024
Q4 | $119M | Sell |
496,301
-97,019
| -16% | -$23.3M | 0.04% | 386 |
|
|
2024
Q3 | $161M | Sell |
593,320
-143,970
| -20% | -$39M | 0.06% | 298 |
|
|
2024
Q2 | $183M | Sell |
737,290
-8,774
| -1% | -$2.18M | 0.07% | 252 |
|
|
2024
Q1 | $108M | Buy |
746,064
+34,372
| +5% | +$4.99M | 0.05% | 360 |
|
|
2023
Q4 | $141M | Buy |
711,692
+97,333
| +16% | +$19.3M | 0.06% | 309 |
|
|
2023
Q3 | $103M | Sell |
614,359
-60,409
| -9% | -$10.2M | 0.05% | 354 |
|
|
2023
Q2 | $128M | Buy |
674,768
+20,988
| +3% | +$3.98M | 0.06% | 315 |
|
|
2023
Q1 | $131M | Sell |
653,780
-13,753
| -2% | -$2.76M | 0.07% | 289 |
|
|
2022
Q4 | $150M | Sell |
667,533
-528,376
| -44% | -$119M | 0.08% | 261 |
|
|
2022
Q3 | $240M | Buy |
1,195,909
+289,375
| +32% | +$58.2M | 0.14% | 164 |
|
|
2022
Q2 | $126M | Buy |
906,534
+31,584
| +4% | +$4.38M | 0.1% | 228 |
|
|
2022
Q1 | $142M | Buy |
874,950
+620,695
| +244% | +$101M | 0.1% | 236 |
|
|
2021
Q4 | $37.6M | Sell |
254,255
-6,114
| -2% | -$905K | 0.02% | 538 |
|
|
2021
Q3 | $49.2M | Buy |
260,369
+46,060
| +21% | +$8.7M | 0.03% | 450 |
|
|
2021
Q2 | $36.3M | Buy |
+214,309
| New | +$36.3M | 0.03% | 521 |
|